# Eli Lilly and Company (LLY) — Q3-2021 Earnings Results

**Report date:** 2021-10-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q3-2021

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.94 | N/A | -1.77% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about market conditions affecting performance. They remain focused on strategic initiatives to drive future growth.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on long-term growth despite current pressures.

### Guidance Changes

No guidance updates were provided during the call.

### What It Means

Eli Lilly's earnings report shows a slight miss on EPS, indicating some challenges the company is facing. Without revenue figures available, it's hard to assess the full impact. The lack of guidance may leave investors uncertain about the company's future direction. The stock reaction is currently not available, which adds to the ambiguity surrounding the report.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q3-2021_